While it is worth noting that the frequency of oncogenic KRAS mutations we detected by ddPCR in CHCs is similar to what has been reported for PDAC-derived CTCs by the same method57, it is unknown if this reflects conserved biology among disseminated tumor cell populations or is possibly related to the limitations of ddPCR analysis. Here, KRAS is linked to neoplasm.